| Literature DB >> 27919211 |
Sahila Mohammed Marunnan1,2, Babitha Pallikkara Pulikkal3, Anitha Jabamalairaj2, Srinivas Bandaru4, Mukesh Yadav4, Anuraj Nayarisseri4,5, Victor Arokia Doss6.
Abstract
BACKGROUND: Alterations in GABAnergic system are implicated in the pathophysiology of schizophrenia. Available antipsychotics that target GABA receptor form a desirable therapeutic strategy in the treatment regimen of schizophrenia, unfortunately, suffer serious setback due to their prolonged side effects. The present investigation focuses on developing QSAR models from the biological activity of herbal compounds and their derivatives that promise to be alternative candidates to GABA uptake inhibitors.Entities:
Keywords: Linear and non-linear QSAR models; MLR and SVM.; Schizophrenia
Mesh:
Substances:
Year: 2017 PMID: 27919211 PMCID: PMC5725540 DOI: 10.2174/1567201814666161205131745
Source DB: PubMed Journal: Curr Neuropharmacol ISSN: 1570-159X Impact factor: 7.363
Fig. (1)(A): correlation of experimental and predicted pIC50 calculated from linear (MLR) aided tetra variable model for dataset -1 and (B) correlation of experimental and predicted pIC50 calculated from non-linear (SVM) aided tetra variable model for dataset-1.
Fig. (2)(A): correlation of experimental and predicted pIC50 calculated from linear (MLR) aided tetra variable model for dataset -2 and (B) correlation of experimental and predicted pIC50 calculated from non-linear (SVM) aided tetra variable model for dataset-2.
Fig. (3)(A): correlation of experimental and predicted pIC50 calculated from linear (MLR) aided tetra variable model for dataset -3 and (B) correlation of experimental and predicted pIC50 calculated from non-linear (SVM) aided tetra variable model for dataset-3.
Molecular descriptors and forward selection statistics for linear (MLR) and non-linear (SVM) for QSAR dataset 1 (9 Compounds).
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| nR09 | 1 | 0.5097 | 0.6185 | 0.4564 | -0.0114 | |
| nR09, BELp2 | 2 | 0.8634 | 0.6036 | 0.1688 | 0.7684 | |
| nR09, G2e, BELp2 | 3 | 0.9012 | 0.5066 | 0.1338 | 0.7860 | |
| nR09, E1u, G2e, BELp2 | 4 | 0.9796 | 0.1682 | 0.0876 | 0.8607 | |
| Mor24m | 1 | 0.8686 | 0.5820 | 0.1453 | 0.5183 | |
| Mor24m, Se1C3C3ad | 2 | 0.9747 | 0.2414 | 0.0576 | 0.8455 | |
| Mor24m, Se1C3C3ad, Mp | 3 | 0.9984 | 0.0611 | 0.0140 | 0.9441 | |
| Mor24m, Se1C3C3ad, Mp, Hnar | 4 | 1.0000 | 0.0094 | 0.0029 | 0.9250 |
Observed and predicted pIC50 values for tetra- variable model using SVM and MLR dataset 1 (9 Compounds).
|
|
|
|
|
|---|---|---|---|
|
|
| ||
| 4.699 | 4.531 | 4.687 | |
| 4.301 | 4.368 | 4.289 | |
| 4.301 | 4.388 | 4.307 | |
| 5.398 | 5.455 | 5.402 | |
| 6.000 | 5.895 | 5.994 | |
| 3.699 | 3.645 | 3.699 | |
| 4.658 | 4.703 | 4.652 | |
| 4.495 | 4.633 | 4.498 | |
| 6-methylflavone | 3.921 | 3.854 | 3.915 |
Molecular descriptors and forward selection statistics for linear (MLR) and non-linear (SVM) QSAR dataset 2 (16 Compounds).
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| H0m | 1 | 0.4827 | 1.1753 | 0.4315 | 0.2908 | |
| H0m, C-025 | 2 | 0.7114 | 1.0899 | 0.3089 | 0.5508 | |
| H0m, C-025, nBnz | 3 | 0.8670 | 0.5661 | 0.2180 | 0.7736 | |
| H0m, C-025, nBnz, Mor17m | 4 | 0.9274 | 0.4868 | 0.1542 | 0.8547 | |
| GGI9 | 1 | 0.6459 | 1.1049 | 0.3207 | 0.4738 | |
| GGI9, R7v+ | 2 | 0.7902 | 0.7553 | 0.2370 | 0.6831 | |
| GGI9, R7v+, G(O..S) | 3 | 0.8970 | 0.7558 | 0.1135 | 0.7834 | |
| GGI9, R7v+, G(O..S), HATSe | 4 | 0.8803 | 0.7725 | 0.1255 | 0.8155 |
Statistical fitness derived from various statistical parameters of linear and non-linear QSAR models show that models were acceptable in the current form. R2 values indicate a strong confidence level even in bi-variable linear (R2=0.8634) and non-linear (R2=0.9747) QSAR models. R2CV values further confirm the stability of QSAR models
Observed and predicted pIC50 values for tetra- variable model using SVM and MLR dataset 2 (16 Compounds).Nipecotic Acid Tiagabine
|
|
|
|
|
|---|---|---|---|
| Linear (MLR) | Non-linear (SVM) | ||
| 4.089 | 4.121 | 3.555 | |
| 6.553 | 6.606 | 6.299 | |
| 5.866 | 5.529 | 5.756 | |
| 4.910 | 4.843 | 4.862 | |
| 6.027 | 6.062 | 6.010 | |
| 6.187 | 6.510 | 6.173 | |
| 4.559 | 4.745 | 4.559 | |
| 5.553 | 5.749 | 5.560 | |
| 5.149 | 5.390 | 5.149 | |
| 6.167 | 6.051 | 6.082 | |
| 6.469 | 5.982 | 6.482 | |
| 6.076 | 6.004 | 5.372 | |
| 4.178 | 4.213 | 4.179 | |
| 5.907 | 5.903 | 5.907 | |
| 5.824 | 5.955 | 5.835 | |
| 5.363 | 5.211 | 5.732 |
Molecular descriptors and forward selection statistics for linear (MLR) and non-linear (SVM) QSAR dataset 3 (32 Compounds).
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
| W | 1 | 0.3422 | 4.5701 | 1.8949 | 0.2516 | |
| W, EEig07r | 2 | 0.5222 | 4.1811 | 1.5139 | 0.4614 | |
| W, EEig07r, EEig05x | 3 | 0.7109 | 2.9664 | 1.2478 | 0.6503 | |
| W, EEig07r, EEig05x, R8v+ | 4 | 0.8548 | 2.3028 | 0.8479 | 0.8054 | |
| EEig09r | 1 | 0.3134 | 5.8419 | 1.6281 | 0.3524 | |
| EEig09r, Mor08u | 2 | 0.7250 | 3.8783 | 1.0052 | 0.6296 | |
| EEig09r, Mor08u, HATS5e | 3 | 0.8169 | 3.0712 | 0.7513 | 0.7578 | |
| EEig09r, Mor08u, HATS5e, JGI9 | 4 | 0.8973 | 2.3043 | 0.5929 | 0.7947 |
Series 1.Magnolol analogues (1-21) Series 2.Honokiol analogues (1-11).
Observed and predicted Experimental Potential %values for tetra- variable model using SVM and MLR dataset 3 (32 Compounds).
|
|
|
| ||||
|---|---|---|---|---|---|---|
| Linear (MLR) | Non-linear (SVM) | |||||
| H | pentyl | H | 5 | 4.4 | 0.9 | |
| H | hexyl | H | 7 | 6.1 | 5.1 | |
| methyl | butyl | H | 5 | 4.8 | 3.5 | |
| methyl | pentyl | H | 3 | 3.5 | 2.6 | |
| methyl | hexyl | H | 7 | 6.4 | 7.0 | |
| ethyl | propyl | H | 5 | 4.4 | 5.0 | |
| ethyl | butyl | H | 3 | 4.6 | 3.0 | |
| ethyl | pentyl | H | 3 | 3.1 | 3.0 | |
| propyl | pentyl | H | 5 | 5.3 | 3.9 | |
| propyl | hexyl | H | 5 | 2.7 | 4.8 | |
| propyl | heptyl | H | 1 | 1.1 | 3.2 | |
| propyl | octyl | H | 1 | -0.3 | 1.0 | |
| butyl | pentyl | H | 5 | 6.2 | 3.9 | |
| butyl | hexyl | H | 3 | 2.5 | 3.0 | |
| ethyl | pentyl | CH3 | 7 | 7.5 | 6.6 | |
| ethyl | hexyl | CH3 | 5 | 5.0 | 5.0 | |
| propyl | pentyl | CH3 | 1 | 3.3 | 3.0 | |
| propyl | hexyl | CH3 | 1 | 0.5 | 1.0 | |
| pentyl | ethyl | CH3 | 3 | 2.6 | 3.6 | |
| pentyl | propyl | CH3 | 3 | 3.5 | 3.0 | |
| hexyl | propyl | CH3 | 1 | -0.1 | 0.8 | |
| methyl | methyl | - | 1 | 1.1 | 1.0 | |
| ethyl | methyl | - | 3 | 2.8 | 3.0 | |
| propyl | methyl | - | 10 | 9.2 | 10.0 | |
| butyl | methyl | - | 10 | 8.9 | 10.0 | |
| pentyl | methyl | - | 7 | 8.2 | 7.0 | |
| hexyl | methyl | - | 10 | 8.5 | 9.6 | |
| heptyl | methyl | - | 7 | 6.4 | 7.1 | |
| octyl | methyl | - | 1 | 3.1 | 3.2 | |
| hexyl | ethyl | - | 3 | 4.5 | 3.3 | |
| hexyl | propyl | - | 1 | 2.6 | 1.0 | |
| hexyl | isopropyl | - | 1 | 0.5 | 1.0 | |